Abstract

The electronic nose (e-nose) system is a newly developing detection technology for its advantages of non-invasiveness, simple operation, and low cost. However, lung cancer screening through e-nose requires effective pattern recognition frameworks. Existing frameworks rely heavily on hand-crafted features and have relatively low diagnostic sensitivity. To handle these problems, gated recurrent unit based autoencoder (GRU-AE) is adopted to automatically extract features from temporal and high-dimensional e-nose data. Moreover, we propose a novel margin and sensitivity based ordering ensemble pruning (MSEP) model for effective classification. The proposed heuristic model aims to reduce missed diagnosis rate of lung cancer patients while maintaining a high rate of overall identification. In the experiments, five state-of-the-art classification models and two popular dimensionality reduction methods were involved for comparison to demonstrate the validity of the proposed GRU-AE-MSEP framework, through 214 collected breath samples measured by e-nose. Experimental results indicated that the proposed intelligent framework achieved high sensitivity of 94.22%, accuracy of 93.55%, and specificity of 92.80%, thereby providing a new practical means for wide disease screening by e-nose in medical scenarios.

Highlights

  • As estimated, lung cancer has been responsible for close to 1 in 5 deaths in 2018, which remains the leading cause of cancer death [1]

  • TN is the number of true predictions for healthy samples; FN is the number of false predictions for healthy samples; TP is the number of true predictions for lung cancer samples; and FP is the number of false predictions for lung cancer samples

  • High sensitivity indicates low rate of missed diagnosis, i.e., few lung cancer patients are classified as healthy individuals, which is vital for lung cancer detection

Read more

Summary

Introduction

Lung cancer has been responsible for close to 1 in 5 deaths in 2018, which remains the leading cause of cancer death [1]. Survival rate for lung cancer patients [4]. Radiological detection, such as computed tomography or positron-emission tomography, has enabled the lungs to be imaged for diagnosis of cancer [5]. These conventional detection methods are expensive and occasionally miss tumors (low sensitivity), and cannot be used as widespread screening tools [6]. It is crucial to develop an effective diagnosis method for lung cancer, which is feasible for wide screening with high sensitivity, especially for high risk patients [8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call